Historique
Rapport
WHO expert committee on drug dependence. 46th report
Auteur(s) :
OMS / WHO (Organisation mondiale de la santé / World Health Organization) ;
Forty-sixth meeting of the WHO Expert Committee on Drug Dependence (ECDD) (16-19 October 2023; WHO headquarters, Geneva, Switzerland)
Année
2024
Page(s) :
222 p.
Langue(s) :
Anglais
Éditeur(s) :
Genève : OMS / WHO
Collection :
Rapports techniques / Technical report series, 1057
ISBN :
978-92-4-009246-4
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
RECOMMANDATION
;
CONTROLE DES STUPEFIANTS
;
DROIT INTERNATIONAL
;
CANNABIS
;
DROGUES DE SYNTHESE
;
CATHINONES
;
CHIMIE
;
POTENTIEL ADDICTIF
;
FABRICATION
;
PHARMACOLOGIE
;
USAGE THERAPEUTIQUE
;
TOXICOLOGIE
;
OPIOIDES
;
PROTOXYDE D'AZOTE
;
BENZODIAZEPINES
Résumé :
The Forty-sixth Meeting of the World Health Organisation (WHO)'s Expert Committee on Drug Dependence (ECDD) was convened from 16 to 19 October 2023 and was coordinated from the WHO headquarters in Geneva.
The Forty-sixth WHO ECDD critically reviewed six new psychoactive substances: including two benzodiazepines (bromazolam, flubromazepam), one novel synthetic opioid (butonitazene), two cathinones/stimulants (3-CMC, dipentylone) and one dissociative-type substance (2-fluorodeschloroketamine). A critical review to consider international scheduling measures was undertaken for each substance so that the Expert Committee could consider whether information about these substances may justify the scheduling or a change in scheduling of a substance in the 1961 or 1971 Conventions.
In addition, the Forty-sixth ECDD carried out a pre-review of nitrous oxide and carisoprodol to consider whether current information justified a critical review.
This report summarizes the findings of the forty-sixth ECDD meeting.
The Forty-sixth WHO ECDD critically reviewed six new psychoactive substances: including two benzodiazepines (bromazolam, flubromazepam), one novel synthetic opioid (butonitazene), two cathinones/stimulants (3-CMC, dipentylone) and one dissociative-type substance (2-fluorodeschloroketamine). A critical review to consider international scheduling measures was undertaken for each substance so that the Expert Committee could consider whether information about these substances may justify the scheduling or a change in scheduling of a substance in the 1961 or 1971 Conventions.
In addition, the Forty-sixth ECDD carried out a pre-review of nitrous oxide and carisoprodol to consider whether current information justified a critical review.
This report summarizes the findings of the forty-sixth ECDD meeting.